NCT04193631View on ClinicalTrials.gov

Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 7, 2019

Primary Completion Date

December 9, 2019

Study Completion Date

December 9, 2019

Conditions
Musculoskeletal Pain
Interventions
DRUG

Cannabidiol (CBD)

A single dose of Cannabidiol (CBD) when patients experience musculoskeletal pain in the trial.

Trial Locations (1)

19317

Dr. Kimless' Clinic, Chadds Ford

All Listed Sponsors
lead

Pure Green

INDUSTRY

NCT04193631 - Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain | Biotech Hunter | Biotech Hunter